The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global GLP-1 Receptor Antagonist Market Research Report 2025
Synopsis
GLP-1 receptor antagonists are a class of drugs used to treat metabolic diseases such as type 2 diabetes and obesity. They act on the GLP-1 receptor and inhibit the binding of GLP-1 to its receptor, thus blocking the biological effects of GLP-1. These drugs reduce insulin secretion by reducing the effects of GLP-1 and are often used to control blood sugar levels and weight. GLP-1 receptor antagonists are the opposite of GLP-1 receptor agonists, which are drugs that stimulate GLP-1 receptors and promote the biological effects of GLP-1.
The global GLP-1 Receptor Antagonist market was valued at US$ 3538 million in 2023 and is anticipated to reach US$ 5600 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
From the perspective of market size and growth trends, the GLP-1 drug market is growing rapidly. It has achieved great success in sales due to its excellent patient compliance. Take dulaglutide and semaglutide as examples. The global sales of these two drugs in 2022 will reach US$7.44 billion and US$9.342 billion respectively. In addition, the market value of two major pharmaceutical companies, Novo Nordisk and Eli Lilly, has soared due to the popularity of GLP-1 drugs. In the diabetes drug market, GLP-1 drugs have a market share of 39%, surpassing insulin to become the largest type of diabetes treatment drug in the world. In general, the market for GLP-1 receptor antagonists (or GLP-1 receptor agonists) is developing rapidly, and long-acting and oral administration are the main development trends in the future.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GLP-1 Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Receptor Antagonist.
The GLP-1 Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global GLP-1 Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
AstraZeneca
Sanofi
Eli Lilly
Bayer
Merck
Shionogi
Pfizer
Jiangsu Hengrui Pharmaceuticals
Shanghai Fosun Pharmaceutical (Group)
Shanghai Pharmaceutical Industry Research Institute
Segment by Type
Injection
Oral Agent
Segment by Application
Diabetes Treatment
Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
GLP-1 receptor antagonists are a class of drugs used to treat metabolic diseases such as type 2 diabetes and obesity. They act on the GLP-1 receptor and inhibit the binding of GLP-1 to its receptor, thus blocking the biological effects of GLP-1. These drugs reduce insulin secretion by reducing the effects of GLP-1 and are often used to control blood sugar levels and weight. GLP-1 receptor antagonists are the opposite of GLP-1 receptor agonists, which are drugs that stimulate GLP-1 receptors and promote the biological effects of GLP-1.
The global GLP-1 Receptor Antagonist market was valued at US$ 3538 million in 2023 and is anticipated to reach US$ 5600 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
From the perspective of market size and growth trends, the GLP-1 drug market is growing rapidly. It has achieved great success in sales due to its excellent patient compliance. Take dulaglutide and semaglutide as examples. The global sales of these two drugs in 2022 will reach US$7.44 billion and US$9.342 billion respectively. In addition, the market value of two major pharmaceutical companies, Novo Nordisk and Eli Lilly, has soared due to the popularity of GLP-1 drugs. In the diabetes drug market, GLP-1 drugs have a market share of 39%, surpassing insulin to become the largest type of diabetes treatment drug in the world. In general, the market for GLP-1 receptor antagonists (or GLP-1 receptor agonists) is developing rapidly, and long-acting and oral administration are the main development trends in the future.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GLP-1 Receptor Antagonist, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Receptor Antagonist.
The GLP-1 Receptor Antagonist market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global GLP-1 Receptor Antagonist market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Receptor Antagonist manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Novo Nordisk
AstraZeneca
Sanofi
Eli Lilly
Bayer
Merck
Shionogi
Pfizer
Jiangsu Hengrui Pharmaceuticals
Shanghai Fosun Pharmaceutical (Group)
Shanghai Pharmaceutical Industry Research Institute
Segment by Type
Injection
Oral Agent
Segment by Application
Diabetes Treatment
Research
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of GLP-1 Receptor Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of GLP-1 Receptor Antagonist in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 GLP-1 Receptor Antagonist Market Overview
1.1 Product Definition
1.2 GLP-1 Receptor Antagonist by Type
1.2.1 Global GLP-1 Receptor Antagonist Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Oral Agent
1.3 GLP-1 Receptor Antagonist by Application
1.3.1 Global GLP-1 Receptor Antagonist Market Value by Application (2024-2030)
1.3.2 Diabetes Treatment
1.3.3 Research
1.3.4 Other
1.4 Global GLP-1 Receptor Antagonist Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Receptor Antagonist Revenue 2019-2030
1.4.2 Global GLP-1 Receptor Antagonist Sales 2019-2030
1.4.3 Global GLP-1 Receptor Antagonist Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 GLP-1 Receptor Antagonist Market Competition by Manufacturers
2.1 Global GLP-1 Receptor Antagonist Sales Market Share by Manufacturers (2019-2024)
2.2 Global GLP-1 Receptor Antagonist Revenue Market Share by Manufacturers (2019-2024)
2.3 Global GLP-1 Receptor Antagonist Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of GLP-1 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Receptor Antagonist, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Receptor Antagonist, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Receptor Antagonist, Date of Enter into This Industry
2.8 Global GLP-1 Receptor Antagonist Market Competitive Situation and Trends
2.8.1 Global GLP-1 Receptor Antagonist Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Receptor Antagonist Players Market Share by Revenue
2.8.3 Global GLP-1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Receptor Antagonist Market Scenario by Region
3.1 Global GLP-1 Receptor Antagonist Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global GLP-1 Receptor Antagonist Sales by Region: 2019-2030
3.2.1 Global GLP-1 Receptor Antagonist Sales by Region: 2019-2024
3.2.2 Global GLP-1 Receptor Antagonist Sales by Region: 2025-2030
3.3 Global GLP-1 Receptor Antagonist Revenue by Region: 2019-2030
3.3.1 Global GLP-1 Receptor Antagonist Revenue by Region: 2019-2024
3.3.2 Global GLP-1 Receptor Antagonist Revenue by Region: 2025-2030
3.4 North America GLP-1 Receptor Antagonist Market Facts & Figures by Country
3.4.1 North America GLP-1 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America GLP-1 Receptor Antagonist Sales by Country (2019-2030)
3.4.3 North America GLP-1 Receptor Antagonist Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Receptor Antagonist Market Facts & Figures by Country
3.5.1 Europe GLP-1 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe GLP-1 Receptor Antagonist Sales by Country (2019-2030)
3.5.3 Europe GLP-1 Receptor Antagonist Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Receptor Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Receptor Antagonist Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific GLP-1 Receptor Antagonist Sales by Region (2019-2030)
3.6.3 Asia Pacific GLP-1 Receptor Antagonist Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Receptor Antagonist Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America GLP-1 Receptor Antagonist Sales by Country (2019-2030)
3.7.3 Latin America GLP-1 Receptor Antagonist Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Receptor Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Receptor Antagonist Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa GLP-1 Receptor Antagonist Sales by Country (2019-2030)
3.8.3 Middle East and Africa GLP-1 Receptor Antagonist Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Receptor Antagonist Sales by Type (2019-2030)
4.1.1 Global GLP-1 Receptor Antagonist Sales by Type (2019-2024)
4.1.2 Global GLP-1 Receptor Antagonist Sales by Type (2025-2030)
4.1.3 Global GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2030)
4.2 Global GLP-1 Receptor Antagonist Revenue by Type (2019-2030)
4.2.1 Global GLP-1 Receptor Antagonist Revenue by Type (2019-2024)
4.2.2 Global GLP-1 Receptor Antagonist Revenue by Type (2025-2030)
4.2.3 Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2019-2030)
4.3 Global GLP-1 Receptor Antagonist Price by Type (2019-2030)
5 Segment by Application
5.1 Global GLP-1 Receptor Antagonist Sales by Application (2019-2030)
5.1.1 Global GLP-1 Receptor Antagonist Sales by Application (2019-2024)
5.1.2 Global GLP-1 Receptor Antagonist Sales by Application (2025-2030)
5.1.3 Global GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2030)
5.2 Global GLP-1 Receptor Antagonist Revenue by Application (2019-2030)
5.2.1 Global GLP-1 Receptor Antagonist Revenue by Application (2019-2024)
5.2.2 Global GLP-1 Receptor Antagonist Revenue by Application (2025-2030)
5.2.3 Global GLP-1 Receptor Antagonist Revenue Market Share by Application (2019-2030)
5.3 Global GLP-1 Receptor Antagonist Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk GLP-1 Receptor Antagonist Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Company Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca GLP-1 Receptor Antagonist Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi GLP-1 Receptor Antagonist Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eli Lilly GLP-1 Receptor Antagonist Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Company Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer GLP-1 Receptor Antagonist Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck GLP-1 Receptor Antagonist Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Shionogi
6.7.1 Shionogi Company Information
6.7.2 Shionogi Description and Business Overview
6.7.3 Shionogi GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Shionogi GLP-1 Receptor Antagonist Product Portfolio
6.7.5 Shionogi Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer GLP-1 Receptor Antagonist Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Jiangsu Hengrui Pharmaceuticals
6.9.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.9.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.9.3 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product Portfolio
6.9.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.10 Shanghai Fosun Pharmaceutical (Group)
6.10.1 Shanghai Fosun Pharmaceutical (Group) Company Information
6.10.2 Shanghai Fosun Pharmaceutical (Group) Description and Business Overview
6.10.3 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product Portfolio
6.10.5 Shanghai Fosun Pharmaceutical (Group) Recent Developments/Updates
6.11 Shanghai Pharmaceutical Industry Research Institute
6.11.1 Shanghai Pharmaceutical Industry Research Institute Company Information
6.11.2 Shanghai Pharmaceutical Industry Research Institute Description and Business Overview
6.11.3 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product Portfolio
6.11.5 Shanghai Pharmaceutical Industry Research Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Receptor Antagonist Industry Chain Analysis
7.2 GLP-1 Receptor Antagonist Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Receptor Antagonist Production Mode & Process
7.4 GLP-1 Receptor Antagonist Sales and Marketing
7.4.1 GLP-1 Receptor Antagonist Sales Channels
7.4.2 GLP-1 Receptor Antagonist Distributors
7.5 GLP-1 Receptor Antagonist Customers
8 GLP-1 Receptor Antagonist Market Dynamics
8.1 GLP-1 Receptor Antagonist Industry Trends
8.2 GLP-1 Receptor Antagonist Market Drivers
8.3 GLP-1 Receptor Antagonist Market Challenges
8.4 GLP-1 Receptor Antagonist Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global GLP-1 Receptor Antagonist Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global GLP-1 Receptor Antagonist Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global GLP-1 Receptor Antagonist Market Competitive Situation by Manufacturers in 2023
Table 4. Global GLP-1 Receptor Antagonist Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global GLP-1 Receptor Antagonist Sales Market Share by Manufacturers (2019-2024)
Table 6. Global GLP-1 Receptor Antagonist Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global GLP-1 Receptor Antagonist Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market GLP-1 Receptor Antagonist Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of GLP-1 Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of GLP-1 Receptor Antagonist, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GLP-1 Receptor Antagonist, Product Type & Application
Table 12. Global Key Manufacturers of GLP-1 Receptor Antagonist, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GLP-1 Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Receptor Antagonist as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GLP-1 Receptor Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global GLP-1 Receptor Antagonist Sales by Region (2019-2024) & (K Dose)
Table 18. Global GLP-1 Receptor Antagonist Sales Market Share by Region (2019-2024)
Table 19. Global GLP-1 Receptor Antagonist Sales by Region (2025-2030) & (K Dose)
Table 20. Global GLP-1 Receptor Antagonist Sales Market Share by Region (2025-2030)
Table 21. Global GLP-1 Receptor Antagonist Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global GLP-1 Receptor Antagonist Revenue Market Share by Region (2019-2024)
Table 23. Global GLP-1 Receptor Antagonist Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global GLP-1 Receptor Antagonist Revenue Market Share by Region (2025-2030)
Table 25. North America GLP-1 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 27. North America GLP-1 Receptor Antagonist Sales by Country (2025-2030) & (K Dose)
Table 28. North America GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America GLP-1 Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe GLP-1 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 32. Europe GLP-1 Receptor Antagonist Sales by Country (2025-2030) & (K Dose)
Table 33. Europe GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe GLP-1 Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific GLP-1 Receptor Antagonist Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific GLP-1 Receptor Antagonist Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific GLP-1 Receptor Antagonist Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific GLP-1 Receptor Antagonist Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific GLP-1 Receptor Antagonist Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America GLP-1 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America GLP-1 Receptor Antagonist Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa GLP-1 Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa GLP-1 Receptor Antagonist Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa GLP-1 Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global GLP-1 Receptor Antagonist Sales (K Dose) by Type (2019-2024)
Table 51. Global GLP-1 Receptor Antagonist Sales (K Dose) by Type (2025-2030)
Table 52. Global GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Table 53. Global GLP-1 Receptor Antagonist Sales Market Share by Type (2025-2030)
Table 54. Global GLP-1 Receptor Antagonist Revenue (US$ Million) by Type (2019-2024)
Table 55. Global GLP-1 Receptor Antagonist Revenue (US$ Million) by Type (2025-2030)
Table 56. Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2019-2024)
Table 57. Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2025-2030)
Table 58. Global GLP-1 Receptor Antagonist Price (US$/Dose) by Type (2019-2024)
Table 59. Global GLP-1 Receptor Antagonist Price (US$/Dose) by Type (2025-2030)
Table 60. Global GLP-1 Receptor Antagonist Sales (K Dose) by Application (2019-2024)
Table 61. Global GLP-1 Receptor Antagonist Sales (K Dose) by Application (2025-2030)
Table 62. Global GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Table 63. Global GLP-1 Receptor Antagonist Sales Market Share by Application (2025-2030)
Table 64. Global GLP-1 Receptor Antagonist Revenue (US$ Million) by Application (2019-2024)
Table 65. Global GLP-1 Receptor Antagonist Revenue (US$ Million) by Application (2025-2030)
Table 66. Global GLP-1 Receptor Antagonist Revenue Market Share by Application (2019-2024)
Table 67. Global GLP-1 Receptor Antagonist Revenue Market Share by Application (2025-2030)
Table 68. Global GLP-1 Receptor Antagonist Price (US$/Dose) by Application (2019-2024)
Table 69. Global GLP-1 Receptor Antagonist Price (US$/Dose) by Application (2025-2030)
Table 70. Novo Nordisk Company Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Novo Nordisk GLP-1 Receptor Antagonist Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. AstraZeneca GLP-1 Receptor Antagonist Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Sanofi GLP-1 Receptor Antagonist Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Eli Lilly Company Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Eli Lilly GLP-1 Receptor Antagonist Product
Table 89. Eli Lilly Recent Developments/Updates
Table 90. Bayer Company Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Bayer GLP-1 Receptor Antagonist Product
Table 94. Bayer Recent Developments/Updates
Table 95. Merck Company Information
Table 96. Merck Description and Business Overview
Table 97. Merck GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Merck GLP-1 Receptor Antagonist Product
Table 99. Merck Recent Developments/Updates
Table 100. Shionogi Company Information
Table 101. Shionogi Description and Business Overview
Table 102. Shionogi GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Shionogi GLP-1 Receptor Antagonist Product
Table 104. Shionogi Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Pfizer GLP-1 Receptor Antagonist Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Jiangsu Hengrui Pharmaceuticals Company Information
Table 111. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 112. Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product
Table 114. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 115. Shanghai Fosun Pharmaceutical (Group) Company Information
Table 116. Shanghai Fosun Pharmaceutical (Group) Description and Business Overview
Table 117. Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product
Table 119. Shanghai Fosun Pharmaceutical (Group) Recent Developments/Updates
Table 120. Shanghai Pharmaceutical Industry Research Institute Company Information
Table 121. Shanghai Pharmaceutical Industry Research Institute Description and Business Overview
Table 122. Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product
Table 124. Shanghai Pharmaceutical Industry Research Institute Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. GLP-1 Receptor Antagonist Distributors List
Table 128. GLP-1 Receptor Antagonist Customers List
Table 129. GLP-1 Receptor Antagonist Market Trends
Table 130. GLP-1 Receptor Antagonist Market Drivers
Table 131. GLP-1 Receptor Antagonist Market Challenges
Table 132. GLP-1 Receptor Antagonist Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of GLP-1 Receptor Antagonist
Figure 2. Global GLP-1 Receptor Antagonist Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global GLP-1 Receptor Antagonist Market Share by Type: 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Oral Agent Product Picture
Figure 6. Global GLP-1 Receptor Antagonist Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global GLP-1 Receptor Antagonist Market Share by Application: 2023 & 2030
Figure 8. Diabetes Treatment
Figure 9. Research
Figure 10. Other
Figure 11. Global GLP-1 Receptor Antagonist Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global GLP-1 Receptor Antagonist Market Size (2019-2030) & (US$ Million)
Figure 13. Global GLP-1 Receptor Antagonist Sales (2019-2030) & (K Dose)
Figure 14. Global GLP-1 Receptor Antagonist Average Price (US$/Dose) & (2019-2030)
Figure 15. GLP-1 Receptor Antagonist Report Years Considered
Figure 16. GLP-1 Receptor Antagonist Sales Share by Manufacturers in 2023
Figure 17. Global GLP-1 Receptor Antagonist Revenue Share by Manufacturers in 2023
Figure 18. Global 5 and 10 Largest GLP-1 Receptor Antagonist Players: Market Share by Revenue in GLP-1 Receptor Antagonist in 2023
Figure 19. GLP-1 Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. Global GLP-1 Receptor Antagonist Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2030)
Figure 22. North America GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2030)
Figure 23. United States GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2030)
Figure 26. Europe GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2030)
Figure 27. Germany GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific GLP-1 Receptor Antagonist Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific GLP-1 Receptor Antagonist Revenue Market Share by Region (2019-2030)
Figure 34. China GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2030)
Figure 42. Mexico GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East and Africa GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2030)
Figure 47. Middle East and Africa GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2030)
Figure 48. Turkey GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE GLP-1 Receptor Antagonist Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of GLP-1 Receptor Antagonist by Type (2019-2030)
Figure 52. Global Revenue Market Share of GLP-1 Receptor Antagonist by Type (2019-2030)
Figure 53. Global GLP-1 Receptor Antagonist Price (US$/Dose) by Type (2019-2030)
Figure 54. Global Sales Market Share of GLP-1 Receptor Antagonist by Application (2019-2030)
Figure 55. Global Revenue Market Share of GLP-1 Receptor Antagonist by Application (2019-2030)
Figure 56. Global GLP-1 Receptor Antagonist Price (US$/Dose) by Application (2019-2030)
Figure 57. GLP-1 Receptor Antagonist Value Chain
Figure 58. GLP-1 Receptor Antagonist Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
